MDB vs ZYME · rev $2.46B vs rev $76.3M
MongoDB (MDB) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
MongoDB (MDB) is a software - infrastructure company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MDB revenue for 2026-01-31 was $2.46B. Net income was -$71.2M. Revenue was up 22.8% from 2025-01-31 to 2026-01-31. MDB currently screens at market cap $17.16B.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MDB currently screens at market cap $17.16B. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MDB and ZYME stock pages for the full models.
Not investment advice.